European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1% to 1,860.69 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 11% and 6.3% respectively. They were followed by lender Banco Santander (SAN) and biopharmaceutical company DBV Technologies (DBVT), which increased 4.2% and 2.2% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and brewing company Anheuser-Busch InBev (BUD), which dropped 2.3% and 2.2% respectively. They were followed by consumer goods company Unilever (UL) and biotech firm Evaxion (EVAX), which lost 1.6% and 0.6% respectively.

From the UK and Ireland, the gainers were led by lender HSBC (HSBC) and mining company BHP Group (BHP), which rose 6.9% and 3.1% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which were up 2.2% and 1.6% respectively.

The decliners from the UK and Ireland were led by alcoholic beverage company Diageo (DEO) and biopharmaceutical company Amarin (AMRN), which fell 13.4% and 10.2% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and hospitality company InterContinental Hotels Group (IHG), which were down 0.9% and 0.7% respectively.